CoreAge Rx vs Goldspan Health

The verdict for women

CoreAge Rx edges out Goldspan Health on the Metabolic-Fit Score, 92 to 31 (A− vs C). Mothers who want a fixed monthly price, a real clinician rather than an intake quiz, and uninterrupted nationwide access to both semaglutide and tirzepatide while they work out the timing around pregnancy or weaning.

Goldspan Health is still a genuine option — two things shape this listing more than the price does. Goldspan publishes no figure anywhere on its own website — not on the homepage, not on the weight-loss category page — and every product instead links out to a separate storefront on another domain, where semaglutide finally reads $229 and tirzepatide $299, each paired with B12. That storefront then advertises the price as monthly while stating that a new supply arrives automatically every four weeks, which means thirteen charges a year rather than twelve: about $2,977 for semaglutide and $3,887 for tirzepatide, roughly $230 and $300 more than a monthly reading implies. Both figures were already among the higher compounded rates here before that adjustment. What is on the credit side is real: a longevity platform with eleven protocol categories, medication dispensed through licensed 503A and 503B pharmacies, and a flat price at any dose. The fifty-state claim on the homepage is qualified by the terms, which say some therapies are unavailable in some states. Weigh the six women's-health factors below against your own priorities.